stockrow
Saturday 7 November 2026
Export HITI’s income statement to Excel — free account
High Tide Inc.
HITI Healthcare Pharmaceutical Retailers
High Tide Inc.’s revenue for fiscal 2025 (year ended October 2025) was $424.0 million, up 10.5% from fiscal 2024.
- Revenue
- +30.7%
- EPS
- +800.0%
- Free cash flow
- −7.91%
- Total debt
- +54.7%
Quarter to July 2026, against a year earlier
2.63
0.00
0.00%
Follow HITI
Alert me
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.60 | 0.44 | 0.44 | 0.36 | |
P/FCF ratio |
26.38 | 14.44 | 18.42 | 16.97 | |
P/Operating CF |
91.81 | 46.70 | 65.42 | 26.65 | |
P/B ratio |
3.48 | 2.68 | 2.89 | 2.20 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.69 | 0.52 | 0.53 | 0.45 | |
EV/EBITDA |
41.43 | 22.95 | 17.95 | 13.22 | |
EV/Operating CF |
17.12 | 11.40 | 14.21 | 13.51 | |
EV/FCF |
30.10 | 17.33 | 22.28 | 21.07 | |
Quick Ratio |
0.54 | 0.59 | 0.49 | 0.59 | |
Current Ratio |
1.37 | 1.43 | 1.46 | 1.50 | |
Net Debt/EBITDA |
(3.78) | 5.27 | 5.00 | 4.23 | |
Debt/Assets |
28.22% | 29.22% | 28.23% | 30.07% | |
Debt/Equity |
0.96 | 0.99 | 0.96 | 0.93 | |
Asset Turnover |
1.97 | 2.18 | 2.33 | 2.29 | |
Operating CF/Net income |
(0.09) | 4.86 | (22.82) | 0.88 | |
Capex/Depreciation |
(0.48) | (0.28) | (0.28) | (0.29) | |
Interest Coverage |
(4.89) | 0.39 | 1.17 | 1.56 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
16.63% | 16.72% | 16.91% | 16.25% | |
Intangible Assets out of Total Assets |
0.37 | 0.37 | 0.36 | 0.35 | |
Share Based Compensation of Revenue |
0.37% | 0.21% | 0.49% | 0.43% | |
Graham Net Nets |
(0.31) | (0.40) | (0.39) | (0.39) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(13.55%) | (17.40%) | (14.82%) | (13.09%) | |
Free Cash Flow Yield |
3.79% | 6.93% | 5.43% | 5.89% | |
Revenue per Share |
1.44 | 1.47 | 1.49 | 1.62 | |
Operating CF per Share |
0.03 | 0.05 | 0.04 | 0.08 | |
Capex per Share |
(0.02) | (0.02) | (0.01) | (0.01) | |
Free Cash Flow per Share |
0.01 | 0.03 | 0.02 | 0.07 | |
Cash per Share |
0.42 | 0.38 | 0.30 | 0.38 | |
Shareholders Equity per Share |
0.89 | 0.84 | 0.85 | 0.98 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.89 | 0.84 | 0.85 | 0.98 | |
Free Cash Flow |
0.75 | 2.62 | 1.99 | 5.79 | |
Working Capital |
26.39 | 29.38 | 30.22 | 34.69 | |
Capital Expenditures |
(2.03) | (1.61) | (1.29) | (1.31) | |
Net Current Asset Value |
(78.09) | (79.24) | (83.54) | (74.06) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
3.22 | 4.35 | 3.78 | 4.94 | |
Average Payables |
25.61 | 25.46 | 27.95 | 26.77 | |
Average Inventory |
34.84 | 34.72 | 36.07 | 35.53 | |
Average Assets |
215.04 | 207.79 | 208.42 | 227.01 | |
Average Common Equity |
90.14 | 87.80 | 87.08 | 95.16 |
Columns are period end dates · fundamentals updated 25 Oct 2026